Literature DB >> 27294355

MicroRNA-132 targets PEA-15 and suppresses the progression of astrocytoma in vitro.

Fei Geng1,2, Jian-Lin Wu1,2, Gui-Feng Lu3, Zhi-Ping Liang1,2, Zhuo-Li Duan1,2, Xi Gu4,5.   

Abstract

Gliomas are highly malignant tumors, the most common of which are astrocytomas. A growing number of studies suggest that dysregulation of miRNAs is a frequent event contributing to the pathogenesis of gliomas. In this study, we found that over-expression of miR-132 inhibited cell proliferation and migration and triggered apoptosis, while knockdown of miR-132 showed opposite effects. PEA-15 was identified as a direct target of miR-132. Reintroduction of PEA-15 without 3'UTR region reversed the inhibitory effects of miR-132 on cell proliferation, migration, and apoptosis. MiR-132 was inversely correlated with the PEA-15 expression. CREB (cAMP response element binding protein) and KLF (Krüppel-like factor 8) were conformed as transcription factors of miR-132, which bidirectionally regulate the expression of miR-132. Our study suggests that miR-132 is an important tumor suppressor of astrocytoma progression by targeting PEA-15, while CREB and KLF can modulate the expression of miR-132, thus providing new insight into the molecular mechanisms underlying astrocytoma progression in vitro.

Entities:  

Keywords:  Astrocytoma; CREB; Glioma; KLF; MiR-132; PEA-15

Mesh:

Substances:

Year:  2016        PMID: 27294355     DOI: 10.1007/s11060-016-2173-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  43 in total

1.  DNA methylation silences miR-132 in prostate cancer.

Authors:  A Formosa; A M Lena; E K Markert; S Cortelli; R Miano; A Mauriello; N Croce; J Vandesompele; P Mestdagh; E Finazzi-Agrò; A J Levine; G Melino; S Bernardini; E Candi
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

2.  miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.

Authors:  Yong-Bin Zheng; Hai-Ping Luo; Qiang Shi; Zhi-Nan Hao; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Gao-Chun Xiao; Shi-Lun Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

3.  microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus.

Authors:  Stephen T Magill; Xiaolu A Cambronne; Bryan W Luikart; Daniel T Lioy; Barbara H Leighton; Gary L Westbrook; Gail Mandel; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

Authors:  Shuyu Zhang; Jun Hao; Fang Xie; Xiangui Hu; Cong Liu; Jian Tong; Jundong Zhou; Jinchang Wu; Chenghao Shao
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

7.  Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Xufu Wei; Cui Tan; Chengyong Tang; Guosheng Ren; Tingxiu Xiang; Zhu Qiu; Rui Liu; Zhongjun Wu
Journal:  Cell Signal       Date:  2013-01-30       Impact factor: 4.315

8.  Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy.

Authors:  Chunxiao Wu; Jiakai Lin; Michelle Hong; Yukti Choudhury; Poonam Balani; Doreen Leung; Lam H Dang; Ying Zhao; Jieming Zeng; Shu Wang
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro.

Authors:  Hangzhou Wang; Xue-Tao Li; Chun Wu; Zhi-Wu Wu; Yan-Yan Li; Tian-Quan Yang; Gui-Lin Chen; Xue-Shun Xie; Yu-Lun Huang; Zi-Wei Du; You-Xin Zhou
Journal:  Onco Targets Ther       Date:  2015-11-03       Impact factor: 4.147

View more
  3 in total

1.  High Expression of PEA15 Is Associated With Patient Survival in Malignant Pleural Mesothelioma.

Authors:  Shajedul Islam; Takao Kitagawa; Yasuhiro Kuramitsu
Journal:  Cancer Diagn Progn       Date:  2021-07-03

2.  Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation.

Authors:  Mahafarin Maralani; Dariush Shanehbandi; Milad Asadi; Shahriar Hashemzadeh; Khalil Hajiasgharzadeh; Hossein Mashhadi Abdolahi; Behzad Baradaran; Marc Peeters
Journal:  Wien Klin Wochenschr       Date:  2021-08-31       Impact factor: 1.704

3.  Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132.

Authors:  Ke Zhou; Chi Zhang; Hui Yao; Xuewen Zhang; Youxin Zhou; Yanjun Che; Yulun Huang
Journal:  Mol Cancer       Date:  2018-07-27       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.